Would you like to join an international team working to improve the future of healthcare? Do you want to enhance the lives of millions of people? Grifols is a global healthcare company that since 1909 has been working to improve the health and well-being of people around the world. We are leaders in plasma-derived medicines and transfusion medicine and develop, produce and market innovative medicines, solutions and services in more than 110 countries and regions.
At Grifols, we believe that diversity adds value to our business, our teams, and our culture. We are committed to equal employment opportunities that foster an inclusive environment.
Support a successful and value-added implementation of Grifols Biopharma’s monthly Product Planning process in the context of Integrated Business Planning (IBP, advanced S&OP) that enables the company long term strategic plan by ensuring product portfolio changes (new product introduction, developments in already marketed products and discontinuations) are aligned with the strategy, compliant with all requirements and executed in a timely, efficient and effective manner.
The role-holder shall have a significant impact on the accuracy of Biopharma portfolio project plan and shall be the ‘go to’ person for information/updates/escalations of assigned projects.
The position will primarily be based in Grifols Worldwide Operations, Dublin, Ireland with travel expected in line with business needs to other Grifols locations.
We understand that self-doubt can hold talented individuals back from applying for opportunities. We encourage everyone who meets the qualifications to apply – we're excited to hear from you
#LI-FD1
Location: Grange Castle International Business Park, Grange, Co. Dublin, D22 K2R3

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world.
A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries.
Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life.
Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases.
With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth.
People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers.
In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all.
To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.